niceritrol has been researched along with Hypolipoproteinemia in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oida, K | 1 |
| Nakai, T | 1 |
| Tamai, T | 1 |
| Kutsumi, Y | 1 |
| Kobayashi, T | 1 |
| Hayashi, T | 1 |
| Yamada, S | 1 |
| Takeda, R | 1 |
1 other study available for niceritrol and Hypolipoproteinemia
| Article | Year |
|---|---|
Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hypertension; Hypolipoprotein | 1982 |